1628
clinical study

Detection of intracranial hemorrhage on CT of the brain using a deep learning algorithm

Materials & Methods

500 non-contrast enhanced CT’s of the brain performed in June, July and Aug. 2018 were independently analyzed on the presence of pathological hyperdensities by a deep learning software package and a fourth-year radiology resident. Their results were compared to a “gold standard analysis,” performed by a senior neuroradiologists. 

Results

Pathological hyperdensities were present in 134/500 patients, the majority of which were hemorrhages (128/134; 95.5%). Pathological hyperdensities were correctly identified by Aidoc software in 125/134 cases (93.3%), compared to 133/134 (99.3%) for the resident. Aidoc’s false-negative ratio was 9/134 (6.7%). When no pathological hyperdensities were present, the exam was rated negative by Aidoc software in 345/366 cases (94.3%), compared to 362/366 (98.9%) for the resident. Aidoc’s false-positive ratio was 21/366 (5.7%). The use of a deep learning algorithm for the detection of pathological intracranial hyper densities helped to detect urgent cases more quickly. 

Conclusions

The AI prototype algorithm has a high degree of diagnostic accuracy for the detection of hyperdensities on CT. Sensitivity and specificity are balanced, which is a prerequisite for its clinical usefulness.

Explore the Latest AI Insights, Trends and Research

Deepak Srikant

<p>Deepak Srikant is a global marketing executive with over 20 years of experience, specializing in the commercialization of medical devices and digital health solutions. He has a proven track record in driving growth, having led successful go-to-market strategies, product launches and market expansions across the U.S. and EMEA.</p> <p>Srikant’s expertise extends to upstream and downstream marketing, professional education and sales enablement. His leadership at companies such as Silk Road Medical (acquired by Boston Scientific) and Aptus Endosystems (acquired by Medtronic) has consistently resulted in revenue growth, enhanced customer retention and successful product adoption.</p> <p>Srikant holds an MBA from the Yale School of Management and a bachelor’s degree in mechanical engineering from Rensselaer Polytechnic Institute. Currently, he leads product marketing for Aidoc’s cardiovascular service line.</p>

Laci Costa

<p>Laci Costa is the Director of Neurovascular Product Marketing at Aidoc. She leads marketing and commercial strategy for the neuro AI portfolio of products. She has 16 years of experience working in the medical device and healthcare industry, with over 12 years dedicated to neurovascular solutions.</p> <p>Costa’s known for her expertise in the neurovascular industry, go-to-market experience with new technologies and upstream and downstream product marketing leadership. She’s held various leadership positions in product marketing, clinical education and professional affairs spanning across start-up organizations to large publicly traded companies.</p> <p>Costa holds a bachelor’s degree in psychology from the University of Oklahoma and an MBA from USC Marshall School of Business.</p>

Ayden Jacob, MD, MSc

<p>Ayden Jacob, MD, MSc, is a physician-engineer with expertise in AI, data science and healthcare economics. He’s passionate about leveraging AI and data science to solve complex healthcare issues through the specific prism of economics and finance. At Aidoc, Dr. Jacob’s work focuses on quantifying the clinical and financial impact of innovative AI solutions deployed throughout the healthcare ecosystem.</p> <p>Dr. Jacob’s diverse expertise reflects a commitment to advancing healthcare through data-driven solutions that enhance both patient outcomes and operational effectiveness. A graduate of Yeshiva University and the University of Oxford, Dr. Jacob employs an interdisciplinary approach to innovating at the intersection of clinical medicine, engineering and informatics.</p>